Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Elizabeth G. Nabel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephane Bancel - $28.72M in MRNA purchases and sales in the last 12 months
- Stephen Hoge - $28.43M in MRNA purchases and sales in the last 12 months
- ARCH Venture Partners IX, LLC - $12.50M in LYEL purchases and sales in the last 12 months
- ARCH Venture Fund XIII, L.P. - $12.50M in LYEL purchases and sales in the last 12 months
- Harry Skip Kiil - $5.61M in MDT purchases and sales in the last 12 months
- James M. Mock - $4.69M in MRNA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Elizabeth G. Nabel?
Elizabeth G. Nabel is a corporate insider of Lyell Immunopharma, Inc. (LYEL). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Elizabeth G. Nabel last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 5 filings going back to 2024.
